Stay updated on Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest updates to the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check11 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this aspect.SummaryDifference0.2%
- Check19 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoNo Change Detected
- Check42 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check49 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference2%
- Check64 days agoChange DetectedNew features have been added to the website, while several options related to participant groups, interventions, and data download formats have been removed.SummaryDifference3%
- Check78 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference3%
Stay in the know with updates to Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.